Abstracts

Filters

Clear Filters
All Days Sun, Sep 27 Mon, Sep 28 Tue, Sep 29 Wed, Sep 30

Tuesday, September 29

1:30 PM - 1:40 PM ET

Discussant
Speaker: Thompson, Reid, MD, PhD - Oregon Health & Science University, Portland, OR
1:30 PM - 1:40 PM ET

Discussant
Speaker: Krauss, Daniel, MD, FASTRO - Beaumont Health, Royal Oak, MI
2:15 PM - 2:25 PM ET

127 - Reduction in Radiation Dose Based on Chemotherapy Response for Rhabdomyosarcoma: A Report from the Children's Oncology Group Soft Tissue Sarcoma Committee
Speaker: Raghavendra, Brinda, BS - University of North Carolina School of Medicine, Providence, NC
2:15 PM - 2:25 PM ET

280 - Connectome-Informed Cognition-Sparing Stereotactic Brain Radiosurgery: Comparison of Cognitive Outcomes to Historical Controls
Speaker: Puett, Andrew, MD, PhD - UC San Diego, La Jolla, CA
2:15 PM - 2:25 PM ET

286 - First Implementation of an All-In-One Solution with Fully Automatic Workflow for Rectal Cancer Based on an Integrated CT-Linac
Speaker: Tian, Suqing, MD, PhD - Peking University Third Hospital, Beijing, Beijing
2:15 PM - 2:25 PM ET

298 - Innate Lymphoid Cell Plasticity Drives Radiation-Induced Lung Injury
Speaker: Kim, Jaeho, MD, PhD - City of Hope, Duarte, CA
2:15 PM - 2:25 PM ET

304 - Glioblastoma Distant Recurrences Preferentially Occur Along White Matter Tracts Mapped Using Probabilistic Diffusion Tractography
Speaker: Gui, Chengcheng, MD - Johns Hopkins University School of Medicine, Baltimore, MD
2:15 PM - 2:25 PM ET

335 - AI as a Safety Net: Clinical and Dosimetric Impact of Intercepting Undetected Brain Metastases in SRS/SRT
Speaker: Kinz, Marvin, MS - Mass General Brigham, Harvard Medical School, Boston, MA
2:15 PM - 3:30 PM ET

Advances in the Treatment of Brain Metastases
Speaker: Simon, Aaron, MD, PhD - UC Irvine Health, Orange, CA
2:15 PM - 2:25 PM ET

LBA 04 - TRIDENT: Phase 3 Trial of Tumor Treating Fields (TTFields) Therapy Concurrent with Temozolomide (TMZ) Radiochemotherapy Followed by Maintenance TMZ and TTFields for Newly Diagnosed Glioblastoma (ndGBM)
Speaker: Shi, Wenyin, MD, PhD - Thomas Jefferson University, Philadelphia, PA
2:15 PM - 2:25 PM ET

LBA 15 - Primary and Retrospective Analysis of GRECO-2: A Randomized, Double-Blind, Placebo-Controlled Phase II Trial of SABR ± Rucosopasem in Localized Pancreatic Cancer
Speaker: Aguilera, Todd, MD, PhD - UT Southwestern Medical Center, Dallas, TX
2:15 PM - 3:30 PM ET

Radiation-Immune Crosstalk in Tumor and Normal Tissue Response
Speaker: McGee, Heather, MD, PhD - City of Hope Department of Radiation Oncology, Duarte, CA